Cite

HARVARD Citation

    Zheng, Y. et al. (2020). DBDx-based drug combinations show highly potent therapeutic efficacy against human pancreatic cancer xenografts in athymic mice. Cancer biology & therapy. 21 (8), pp. 749-757. [Online]. 
  
Back to record